Infectious complications of monoclonal antibodies used in cancer therapy: a systematic review of the evidence from randomized controlled trials.

Petros I. Rafailidis , Ourania K. Kakisi , Konstantinos Vardakas , Matthew E. Falagas
Cancer 109 ( 11) 2182 -2189

74
2007
Trends of Mortality in Greece Prior to and During Its Current Financial Crisis (2009-2015).

Konstantinos Vardakas , Katerina Apiranthiti , Spiridoula Almpani , Dominiki Heliou
Rambam Maimonides Medical Journal 10 ( 3)

1
2019
Incidence, characteristics, and outcomes of patients with bone and joint infections due to community-associated...

Konstantinos Vardakas , Ioannis Gkegkes , Petros I Rafailidis , Matthew Falagas

2013
Category: 5a. Mechanisms of action, preclinical data & pharmacology of antibacterial agents

Matthew E Falagas , Tilemachos Skalidis , Konstantinos Vardakas , Nikolaos Legakis

Acinetobacter infections: a growing threat for critically ill patients.

M. E. FALAGAS , E. A. KARVELI , I. I. SIEMPOS , K. Z. VARDAKAS
Epidemiology and Infection 136 ( 8) 1009 -1019

66
2008
Clostridium difficile in Crete, Greece: epidemiology, microbiology and clinical disease

G. SAMONIS , K. Z. VARDAKAS , G. S. TANSARLI , D. DIMOPOULOU
Epidemiology and Infection 144 ( 1) 161 -170

3
2016
www. expert-reviews. com 969

PL Almasio , M Altfeld , S Aslam , T Baranek

www. expert-reviews. com 111

N Ali , Y Av-Gay , P Batra , C Baxter

Characteristics and outcomes of intensive care unit patients with carbapenem-resistantklebsiella pneumoniaebacteraemia

K Vardakas , D Matthaiou , E Antupa , E Pappas
Clinical Microbiology & Infection 16 S358 -S358

2010
The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients

Alberto E Maraolo , Silvia Corcione , Adriano Grossi , Alessio Signori
Infectious Diseases and Therapy 10 ( 1) 541 -558

2021
Deaths Attributable to Carbapenem-ResistantEnterobacteriaceaeInfections

Matthew E. Falagas , Giannoula S. Tansarli , Drosos E. Karageorgopoulos , Konstantinos Z. Vardakas
Emerging Infectious Diseases 20 ( 7) 1170 -1175

298
2014
Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.

Legakis NJ Falagas ME , Skalidis T , Vardakas KZ , Hellenic Cefiderocol Study Group
Journal of Antimicrobial Chemotherapy 72 ( 6) 1704 -1708

93
2017
A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies.

George Samonis , Konstantinos Z. Vardakas , Sofia Maraki , Giannoula S. Tansarli
Supportive Care in Cancer 21 ( 9) 2521 -2526

33
2013
Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis

Konstantinos Z. Vardakas , Matthew E. Falagas
International Journal of Antimicrobial Agents 49 ( 2) 233 -238

52
2017
Colistin loading dose: evaluation of the published pharmacokinetic and clinical data.

Konstantinos Z. Vardakas , Konstantinos Rellos , Nikolaos A. Triarides , Matthew E. Falagas
International Journal of Antimicrobial Agents 48 ( 5) 475 -484

12
2016
Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.

Konstantinos Z. Vardakas , Georgios L. Voulgaris , George Samonis , Matthew E. Falagas
International Journal of Antimicrobial Agents 51 ( 1) 1 -9

30
2018
Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals

Hellenic TP-6076Study Falagas ME , Skalidis T , Vardakas KZ , Voulgaris GL
International Journal of Antimicrobial Agents 52 ( 2) 269 -271

13
2018
Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences.

Matthew E. Falagas , Florentia Athanasaki , Georgios L. Voulgaris , Nikolaos A. Triarides
International Journal of Antimicrobial Agents 53 ( 1) 22 -28

127
2019